Properties
Description
Orelabrutinib is a compound designed to block Bruton’s tyrosine kinase (BTK), an enzyme essential for the proliferation and survival of certain cancerous B cells.
Molecular Formula
C26H25N3O3
Identity
Confirmed by NMR/HPLC/MS.
Applications
Orelabrutinib is a BTK inhibitor, explored for its therapeutic potential in autoimmune conditions.